| Literature DB >> 32797660 |
Meina Yue1, Xiaoyu Li1, Di Liu1, Xue Hu1.
Abstract
BACKGROUND: Salmonella is an important foodborne pathogen that causes acute diarrhea in humans worldwide. This study analyzed the relationships of serotypes and antibiotic resistance with virulence genes of Salmonella isolated from children with salmonellosis.Entities:
Keywords: zzm321990Salmonellazzm321990; antibiotic resistance; children; serotype; virulence genes
Mesh:
Substances:
Year: 2020 PMID: 32797660 PMCID: PMC7755775 DOI: 10.1002/jcla.23525
Source DB: PubMed Journal: J Clin Lab Anal ISSN: 0887-8013 Impact factor: 3.124
Primer sequences and lengths of 20 virulence genes of Salmonella
| Location | Primer name | Primer sequence (5′‐3′) | Length (bp) | Hybridization temperature and references |
|---|---|---|---|---|
| SPI‐1 | hilA‐F | GACAGAGCTGGACCACAATAAGACA | 312 | 55°C |
| hilA‐R | GAGCGTAATTCATCGCCTAAAC | |||
| SPI‐1 | sipB‐F | GGACGCCGCCCGGGAAAAACTCTC | 875 | 66.5°C |
| sipB‐R | ACACTCCCGTCGCCGCCTTCACAA | |||
| SPI‐1 | prgH‐F | CTTCAGGYCAACTCCCTGATATAC | 961 | 55°C |
| prgH‐R | CCCTTGAGCCAGTCATCTTT | |||
| SPI‐2 | ssrB‐F | CTCATTCTTCGGGCACAGTTA | 558 | 55°C |
| ssrB‐R | CCTTATTACCCTGGCCTCATTT | |||
| SPI‐3 | marT‐F | CGTCGTCTCACAACAAACATTC | 556 | 55°C |
| marT‐R | CTGACAAATCAATGCCGTAACC | |||
| SPI‐3 | mgtC‐F | AAAGACAATGGCGTCAACGTATGG | 500 | 65°C |
| mgtC‐R | TTCTTTATAGCCCTGTTCCTGAGC | |||
| SPI‐4 | siiD‐F | GTCAGGGCGTTATCACTACTAAA | 826 | 55°C |
| siiD‐R | TTCACATCGGCCAGCATAG | |||
| SPI‐5 | sopB‐F | TCACTAAAAACCCAGGAGGCTTTT | 1000 | 65°C |
| sopB‐R | CGCCATCTTTATTGCGGATTTTTA | |||
| SPI‐6 | pagN‐F | TTCCAGCTTCCAGTACGTTTAG | 440 | 55°C |
| pagN‐R | GCCTTTGTGTCTGCATCATAAG | |||
| SPI‐7 |
vexA‐F vexA‐R |
AAACTAAGCGCTCCCGATAC CAGTCGCGCAGTGAAATAATG | 504 | 55°C |
| SPI‐8 |
nlpI‐F nlpI‐R |
AGTCTTGGTTTGAGGGCATTAG TTCTTTCGCCTGCTTCTCATTA | 333 | 55°C |
| SPI‐9 | bapA‐F | TAAGCGTCGGACTTGGAATG | 543 | 55°C |
| bapA‐R | CGTTCTTCAGCGTGTAGGTATAG | |||
| SPI‐11 | pagC‐F | CGCCTTTTCCGTGGGGTATGC | 454 | 66.5°C |
| pagC‐R | GAAGCCGTTTATTTTTGTAGAGGAGATGTT | |||
| SPI‐12 | oafA‐F | CGAGTGACTGGAACCAAAGA | 510 | 55°C |
| oafA‐R | CAAGCATAGAGCCAGAGTAGAG | |||
| SPI‐19 | icmF‐F | GCGTAGTCCAGATGAGACATTAG | 724 | 55°C |
| icmF‐R | GCGGCCAGATAGACGATATTT | |||
| Plasmid | spvB‐F | CTATCAGCCCCGCACGGAGAGCAGTTTTTA | 717 | 66.5°C |
| spvB‐R | GGAGGAGGCGGTGGCGGTGGCATCATA | |||
| Plasmid | pefA‐F | GCGCCGCTCAGCCGAACCAG | 157 | 66.5°C |
| pefA‐R | GCAGCAGAAGCCCAGGAAACAGTG | |||
| Plasmid | spvR‐F | CCGCTGAGCAGGGTTATTT | 723 | 55°C |
| spvR‐R | CTTGGTCGGGTAATACAAGGAG | |||
| Genome |
cdtB‐F cdtB‐R |
ACAACTGTCGCATCTCGCCCCGTCATT CAATTTGCGTGGGTTCTGTAGGTGCGAGT | 268 | 66.5°C |
| Genome | tolC‐F | GCAGACGCTGATCCTCAATAC | 623 | 55°C |
| tolC‐R | TTGCGCCGACGAAGTTATAC |
Distribution characteristics of serotypes of 61 Salmonella isolates
| Name of the isolate | Number (isolate) | Proportion (%) |
|---|---|---|
|
| 21 | 34.43 |
|
| 12 | 19.67 |
|
| 5 | 8.20 |
|
| 4 | 6.56 |
|
| 3 | 4.92 |
|
| 3 | 4.92 |
|
| 2 | 3.28 |
|
| 2 | 3.28 |
|
| 2 | 3.28 |
|
| 1 | 1.64 |
|
| 1 | 1.64 |
|
| 1 | 1.64 |
|
| 1 | 1.64 |
|
| 1 | 1.64 |
|
| 1 | 1.64 |
|
| 1 | 1.64 |
FIGURE 1Note: Gray indicates that the detection of the virulence gene was positive; white indicates that the detection of the virulence gene was negative; green indicates that the isolate had antibiotic susceptibility; yellow indicates that the antibiotic susceptibility of the isolate was intermediate; red indicates that the isolate was antibiotic‐resistant; and light blue indicates that the ESBL test was negative, while dark blue indicates that the ESBL test was positive
Distribution of antibiotic susceptibility of 61 Salmonella isolates
|
Antimicrobial Agent | Resistant | Intermediate | Susceptible | |||
|---|---|---|---|---|---|---|
| Number of isolates | Rate (%) | Number of isolates | Rate (%) | Number of isolates | Rate (%) | |
| Ampicillin | 39 | 63.93 | 0 | 0.00 | 22 | 36.07 |
| Ampicillin/sulbactam | 34 | 55.74 | 1 | 1.64 | 26 | 42.62 |
| Trimethoprim‐Sulfamethoxazole | 24 | 39.34 | 0 | 0.00 | 37 | 60.66 |
| Aztreonam | 14 | 22.95 | 2 | 3.28 | 45 | 73.77 |
| Cefotaxime | 12 | 19.67 | 3 | 4.92 | 46 | 75.41 |
| Ceftriaxone | 11 | 18.03 | 0 | 0.00 | 50 | 81.97 |
| Ceftazidime | 8 | 13.11 | 0 | 0.00 | 53 | 86.89 |
| Nitrofurantoin | 6 | 9.84 | 9 | 14.75 | 46 | 75.41 |
| Cefepime | 5 | 8.20 | 1 | 1.64 | 55 | 90.16 |
| Ceftizoxime | 5 | 8.20 | 4 | 6.56 | 52 | 85.25 |
| Ciprofloxacin | 3 | 4.92 | 2 | 3.28 | 56 | 91.80 |
| Cefoperazone/sulbactam | 1 | 1.64 | 2 | 3.28 | 58 | 95.08 |
| Piperacillin/tazobactam | 1 | 1.64 | 6 | 9.84 | 54 | 88.52 |
| Levofloxacin | 1 | 1.64 | 0 | 0.00 | 60 | 98.36 |
| Imipenem | 0 | 0.00 | 0 | 0.00 | 61 | 100.00 |
Criteria for cefoperazone/sulbactam were based on Enterobacteriaceae criteria for cefoperazone.
Occurrence of virulence genes in Salmonella serotypes
| Virulence gene | The total number of isolates (N = 61) | Typhimurium (N = 21) | Enteritidis (N = 12) | Stanley (N = 5) | Saintpaul (N = 4) | Others (N = 19) |
|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| prgH | 61 (100.00) | 21 (100.00) | 12 (100.00) | 5 (100.00) | 4 (100.00) | 19 (100.00) |
| ssrB | 61 (100.00) | 21 (100.00) | 12 (100.00) | 5 (100.00) | 4 (100.00) | 19 (100.00) |
| pagC | 61 (100.00) | 21 (100.00) | 12 (100.00) | 5 (100.00) | 4 (100.00) | 19 (100.00) |
| marT | 57 (93.44) | 21 (100.00) | 11 (91.67) | 4 (80.00) | 4 (100.00) | 17 (89.47) |
| hilA | 55 (90.16) | 20 (95.24) | 10 (83.33) | 5 (100.00) | 4 (100.00) | 16 (84.21) |
| sipB | 53 (86.89) | 21 (100.00) | 10 (83.33) | 3 (60.00) | 3 (75.00) | 16 (84.21) |
| mgtC | 53 (86.89) | 21 (100.00) | 8 (66.67) | 4 (80.00) | 4 (100.00) | 16 (84.21) |
| nlpI | 53 (86.89) | 21 (100.00) | 9 (75.00) | 4 (80.00) | 4 (100.00) | 15 (78.95) |
| sopB | 51 (83.61) | 20 (95.24) | 7 (58.33) | 5 (100.00) | 4 (100.00) | 15 (78.95) |
| bapA | 50 (81.97) | 21 (100.00) | 2 (16.67) | 5 (100.00) | 4 (100.00) | 18 (94.74) |
| tolC | 45 (73.77) | 18 (85.71) | 9 (75.00) | 2 (40.00) | 3 (75.00) | 13 (68.42) |
| pagN | 41 (67.21) | 18 (85.71) | 7 (58.33) | 0 (0.00) | 2 (50.00) | 14 (73.68) |
| oafA | 35 (57.38) | 21 (100.00) | 1 (8.33) | 4 (80.00) | 4 (100.00) | 5 (26.32) |
| siiD | 28 (45.90) | 10 (47.62) | 3 (25.00) | 3 (60.00) | 3 (75.00) | 9 (47.37) |
| icmF | 12 (19.67) | 1 (4.76) | 10 (83.33) | 0 (0.00) | 0 (0.00) | 1 (5.26) |
| pefA | 11 (18.03) | 0 (0.00) | 10 (83.33) | 0 (0.00) | 0 (0.00) | 1 (5.26) |
| spvR | 10 (16.39) | 0 (0.00) | 9 (75.00) | 0 (0.00) | 0 (0.00) | 1 (5.26) |
| spvB | 8 (13.11) | 1 (4.76) | 6 (50.00) | 0 (0.00) | 0 (0.00) | 1 (5.26) |
| cdtB | 3 (4.92) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 3 (15.79) |
| vexA | 1 (1.64) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (5.26) |
Correlations between virulence genes and antimicrobial resistance
| Virulence gene × antimicrobial agent |
|
|---|---|
| bapA × Nitrofurantoin | .005 |
| icmF × Nitrofurantoin | .012 |
| spvB × Nitrofurantoin | .008 |
| spvR × Nitrofurantoin | .002 |
| pefA × Nitrofurantoin | .005 |
Table 5 only lists the correlated virulence genes and antimicrobial agents.